# FDA Inspection 944013 - Biomat USA, Inc - September 17, 2015

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/9dadc55f-2d25-46da-8d0e-9447276e5985
Source feed: FDA_Inspections

> FDA Inspection 944013 for Biomat USA, Inc on September 17, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 944013
- Company Name: Biomat USA, Inc
- Inspection Date: 2015-09-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1299022 - 2026-01-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e8e365b4-7d4b-4896-a0fd-ac97dbb7aba3)
- [FDA Inspection 1299022 - 2026-01-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8dd24e60-6466-44de-a359-00349d38fa87)
- [FDA Inspection 1102124 - 2019-07-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/14c57664-074a-44c0-8567-9ba3d15d9ecb)
- [FDA Inspection 767582 - 2012-02-06](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/37881c8c-c2d4-4e8c-9a59-d6b3542c2747)

Company: https://www.keypedia.com/companies/biomat-usa-inc/ca076ea8-8e78-45f5-985c-14d58e1c73a5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d